These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35034581)
21. Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients. Weng X; YangYang ; Cai Y Dis Markers; 2022; 2022():5188006. PubMed ID: 35140820 [TBL] [Abstract][Full Text] [Related]
22. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer. Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024 [TBL] [Abstract][Full Text] [Related]
23. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis. Yin L; Pu N; Thompson E; Miao Y; Wolfgang C; Yu J Clin Cancer Res; 2021 Feb; 27(3):740-748. PubMed ID: 33082211 [TBL] [Abstract][Full Text] [Related]
24. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592 [TBL] [Abstract][Full Text] [Related]
25. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664 [TBL] [Abstract][Full Text] [Related]
26. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Bissolati M; Sandri MT; Burtulo G; Zorzino L; Balzano G; Braga M Tumour Biol; 2015 Feb; 36(2):991-6. PubMed ID: 25318603 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050 [TBL] [Abstract][Full Text] [Related]
28. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521 [TBL] [Abstract][Full Text] [Related]
29. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154 [TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients. Chen J; Cao SW; Cai Z; Zheng L; Wang Q Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439 [TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma. Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380 [TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma. Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530 [TBL] [Abstract][Full Text] [Related]
33. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma. Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007 [TBL] [Abstract][Full Text] [Related]
34. Circulating Tumor Cells Expressing Krüppel-Like Factor 8 and Vimentin as Predictors of Poor Prognosis in Pancreatic Cancer Patients. Zhu P; Liu HY; Liu FC; Gu FM; Yuan SX; Huang J; Pan ZY; Wang WJ Cancer Control; 2021; 28():10732748211027163. PubMed ID: 34378430 [TBL] [Abstract][Full Text] [Related]
35. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma. Wu G; Zhu R; Li Y; Zhao Y; Dai M Oncol Lett; 2018 May; 15(5):7376-7382. PubMed ID: 29725451 [TBL] [Abstract][Full Text] [Related]